Humpath.com - Human pathology

Home > E. Pathology by systems > Reproductive system > Female genital system > Uterus > endometrial stromal sarcoma

endometrial stromal sarcoma

Monday 9 May 2005

ESS

PO

Definition: ESS shows ovoid cells with scattered hyperchromatism, and numerous mitotic figures. It is invasive and likely to show lymphovascular invasion. It is CD10 positive, differentiating the lesion from leiomyosarcoma. Endometrial stromal sarcoma has CD10 positive malignant cells and is invasive.

Images

- low-grade Endometrial Stromal Sarcoma (LG-ESS)

- ESS metastatic to colon

Microscopy

- The microscopy shows ovoid cells with scattered hyperchromatism, and numerous mitotic figures, including atypical mitoses.
- It is invasive and likely to show lymphovascular invasion.

Immunochemistry

It is CD10 positive, differentiating the lesion from leiomyosarcoma.

- SMM-HC+ (smooth muscle myosin heavy chain)
- calponin+

- CD10+

  • CD10+ in endometrial stromal tumors (ESTs) / endometrial stromal sarcoma (ESS) / endometrial stromal nodule (ESN)
  • CD10 have a positive staining in a small number of endometrial stromal sarcomas as well as in normal endometrial stroma.
  • CD10 is a reliable and sensitive immunohistochemical marker of normal endometrial stroma.
  • Positivity, which is often strong and/or diffuse is found in endometrial stromal nodules and low-grade ESS. (11532038)
  • Positive staining with CD10, when strong and diffuse, may be useful in distinguishing these tumours from histological mimics, especially cellular leiomyoma and AGCT which are generally negative.
  • CD10 should be used as part of a panel which might include desmin and alpha-inhibin depending on the differential diagnosis considered.
  • Positive staining with CD10 in a high-grade uterine sarcoma which is negative with muscle markers might indicate endometrial stromal differentiation and identify a group of neoplasms which it is correct to diagnose as high-grade ESS rather than undifferentiated uterine sarcoma. (11532038)

Subtypes

- high-grade endometrial stromal sarcoma

DIfferential diagnosis

See: uterine spindle cell tumors

Endometrial stromal tumors may pose diagnostic challenges particularly when they exhibit variant histologic appearances, involve extrauterine sites, or present as metastatic disease. In such cases, use of immunohistochemical markers and identification of specific nonrandom chromosomal rearrangements may be helpful.

- endometrial stromal nodule

  • Stromal nodule does not have atypical mitoses, and has a lower number of mitosis.

- uterine leiomyoma

  • Classic leiomyoma is not this atypical or cellular (variants of leiomyoma include cellular leiomyoma and atypical leiomyoma).
  • Leiomyoma is not CD10 positive.

- uterine leiomyosarcoma

  • Leiomyosarcoma is not CD10 positive.

Molecular biology

- JAZF1-JJAZ1 fusion gene

- NUTM2-YWHAE fusion gene in high-grade endometrial stromal sarcoma (YWHAE-NUTM2 )
- BCOR-ZC3H7B fusion gene in high-grade endometrial stromal sarcoma (ZC3H7B-BCOR ) (27631520)

Cytogenetics

- t(3;6)(q29;p21.1) (14580778)
- t(7;17)(p15;q21) (JAZF1-JJAZ1 fusion gene)
- t(10;17)(q22;p13) (14529693)
- t(X;17)(p11:q23)

Differential diagnosis

- endometrial stromal tumors

  • benign stromal nodule
  • undifferentiated endometrial sarcoma

- uterine smooth muscle tumors

See also

- extrauterine endometrial stromal sarcoma

References

- Endometrial Stromal Sarcomas With Sex Cord Differentiation Are Associated With PHF1 Rearrangement. D’Angelo E, Ali RH, Espinosa I, Lee CH, Huntsman DG, Gilks B, Prat J. Am J Surg Pathol. 2012 Dec 1. PMID: 23211293